Company Information

TONIRA PHARMA LTD.

NSE : NABSE : 530155ISIN CODE : INE844F01012Industry : Pharmaceuticals & DrugsHouse : Private
BSE19.750 (0 %)
PREV CLOSE ( ) 19.75
OPEN PRICE ( ) 19.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 19.75 (1641)
VOLUME 1831
TODAY'S LOW / HIGH ( )19.00 19.90
52 WK LOW / HIGH ( ) 1919.9
NSE
This Company is not listed in NSE
ChairmanBhailalbhai B Shah
Company SecretaryHeta Mehta
Executive DirectorL K Gupta
Promoter & Non-Executive DirectorJ L Nagori
Harish Kamath
Non Executive Independent DirectorMahesh Bhatt
Rajesh J Shah
Dev Prakash Yadava
Incorporation Year : 1992

Registered Office :

Address : 23-24,G I D C Estate,Nandesari, Vadodara Dist Nandesari,
Gujarat-391340 .

Phone : 0265- 2840795

Industry : Pharmaceuticals & Drugs

Listing : BSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.